Relationships Between Expression level of MicroRNA-146a, STAT1 Protein and Clinical Characteristics in Children with Acute Lymphoblastic Leukemia / 中国实验血液学杂志

OBJECTIVE@#To analyze the relationships between expression levels of serum microRNA-146a, STAT1 protein and clinical characteristics in children with acute lymphoblastic leukemia (ALL).@*METHODS@#A total of 102 children diagnosed as ALL in our hospital from June 2014 to June 2016 were enrolled, and were compared by into groups according to clinical characteristics including sex, age, lymphocyte type, disease risk, chemotherapy stage and gene mutation. Fifty healthy children were chosen as control group. The relative expression of microRNA-146a and STAT1 gene was detected by real-time RT-PCR and the relative level of STAT1 protein was detected by Western blot. The difference of microRNA-146a and STAT1 protein levels between clinical factors and laboratory indexs were compared. Followed-up for 3 years, The difference of overall survival (OS) rates between ALL children with different microRNA-146a and STAT1 protein were compared.@*RESULTS@#The levels of microRNA-146a, STAT1 mRNA and protein in ALL children were significantly higher than those in control group (P＜0.05), but there were no significantly differences in sex, age and lymphocyte type grouping in ALL children (P＞0.05). There were significantly differences in different disease risk, chemotherapy stage and gene mutation groups in ALL children (P＜0.05). Followed-up for 3 years, the OS rate of ALL children with high microRNA-146a and STAT1 protein levels were better than those with low microRNA-146a and STAT1 protein levels (P＜0.05).@*CONCLUSION@#The up-regulation of microRNA-146a and STAT1 protein may be involved in occurrence and development of ALL, which closely relates to clinical characteristics in ALL children, such as disease risk, chemotherapy stage and gene mutation.

Transplantation of neural stem cells via the cisterna magna for treatment of traumatic brain injury in rats / 中华神经医学杂志

Objective To investigate the potential of neural stem cells (NSCs) injected into the cistema magna to migrate into the injured brain tissue to survive and differentiate into neural cells in rats with traumatic brain injury (TBI). Methods Embryonic NSCs cultured in vitro were labeled with BrdU and identified using immunofluorescence assay for nestin and BrdU expression. The labeled NSCs were stereotactically injected into the subarachnoid spaces of rats 24 h after experimental traumatic brain injury. The motor neurological function of the rats was assessed 24 h before and 24 h and 1 and 2 weeks after the injury, and immunohistochemistry was used to detect the expressions of BrdU, MAP2 and GFAP in the brain tissues. Results Positive expressions of nestin and BrdU were detected on the neurospheres by immunofluorescence assay. NSC transplantation resulted in significantly improved motor neurological function of the rats with traumatic brain injury (P<0.05). Immtmohistochemistry demonstrated the presence of BrdU-positive NSCs, MAP2-positive neurons and GFAP-positive glial cells in the traumatic brain tissue of rats 1 and 2 weeks after NSC transplantation. Conclusion Neural stem cells injected via the subarachnoid space can migrate into the injured rat brain tissue and differentiate into neural cells to promote the recovery of motor neurological function of rats with traumatic brain injury.

A case-control study on risk factors for nosocomial infection by extended-spectrum beta-lactamases-producing bacteria / 中华预防医学杂志

<p><b>OBJECTIVE</b>To explore the risk factors for nosocomial infection caused by extended-spectrum beta-lactamases (ESBLs)-producing bacteria in hospitals of Zhejiang province.</p><p><b>METHODS</b>One hundred and eighty-five cases with nosocomial infection (108 men and 77 women, with an average age of 55 +/- 17 years) caused by positive-ESBLs bacteria, including 59 cases of respiratory infection, 71 with urinary infection, ten with blood infection, 30 with wound infection and 59 with other infection, and 77 controls with nosocomial infection (54 men and 23 women, with an average age of 54 +/- 20 years) caused by negative-ESBLs bacteria, including 38 cases of respiratory infection, 20 with urinary infection, six with blood infection, eight with wound infection and five with other infection, from six hospitals in Zhejiang Province were studied during May 1999 to May 2000. Data were analyzed with unconditional logistic regression and principal component analysis (PCA).</p><p><b>RESULTS</b>Multivariate unconditional logistic regression analysis showed that the independent risk factors for nosocomial infection were use of the third generation cephalosporins for more than three days (odds ratio, OR 4.52, 95% confidence interval of OR 2.30 - 8.89), combined use of antibiotics (OR 2.86, 95% CI 1.51 - 5.43), use of quinolones for more than three days (OR 2.44, 95% CI 1.18 - 5.04), use of adrenal cortical hormone (OR 2.16, 95% CI 1.08 - 4.31) and oxygen inhalation (OR 2.56, 95% CI 1.14 - 5.72). Five principal components were extracted from the 14 risk factors for nosocomial infection with ESBLs-producing bacteria by principal component analysis, with a contribution of cumulative variance of 60.2%, and arranged in an order as follows, use of ventilator, tracheal intubation or tracheotomy, oxygen inhalation, retaining needle in vein, indwelling urethral catheter, use of the third generation cephalosporins over three days, hospitalization over ten days, use of quinolones over three days, combined use of antibiotics, use of aminoglycosides antibiotic over a week, use of adrenal cortical hormone, catheterized examination and prophylactic use of antibiotics.</p><p><b>CONCLUSIONS</b>Nosocomial infection with ESBLs-producing bacteria could attribute to multiple factors, mainly to invasive manipulation and use of antibiotics.</p>